Bioinformatics analysis of microarray data from colon cancer patients with known clinical record and p53 mutation status, using the Kaplan–Meier procedure, showed significant association of poor survival with low HIPK2 expression only in tumors expressing WTp53, in agreement with the in vitro data [55] (Table 1). Here, HIPK2 is linked to malignant colon neoplasm.